1 documents found
Information × Registration Number 0218U001105, 0116U008724 , R & D reports Title Development of enzyme linked immunoassay of high sensitivity for p24 HIV1 and HIV2 specific antibodies detection popup.stage_title Head Shevchuck Veronika Alexandrovna, Registration Date 19-01-2018 Organization Рrivate joint-stock company "Scientific production company "Diaproph-Med" popup.description2 Report on research work: 219 p., 24 drawing, 5 tables, add. 9, sources 5. The object of the study is increased sensitivity ELISA kit for the determination of susceptible antibodies against HIV-1/HIV-2 and p24/p26 HIV-1/HIV-2 antigens. The purpose of the work was to create a new highly sensitive diagnostic immunoassay kit for the simultaneous detection of p24/p26 HIV-1/HIV-2 antigens and IgG, IgM, IgA antibodies against HIV-1/HIV-2 in human blood serum or plasma, it to sensitivity and specificity will not yield to foreign CE-marked commercial analogues and the ussng of it will allow to detect HIV at different stages of the infectious process and will increase the safety of donor blood and reduce the rate of spread of HIV infection. Methods of investigation - immunoassay analysis, protein chromatography, microbiological, biochemical, methods of bioconjugation. At the reporting stage, work was carried out on the development and acquisition of biological components for the production of experimental test system samples: recombinant HIV-1 / HIV-2 antigen proteins containing the most immunogenic domains, highly specific monoclonal antibodies to p24 HIV-1 proteins and p26 HIV-2 - anti-p24 / p26 HIV-1 / HIV-2, biotinylated and peroxidase conjugates based on reduced recombinant proteins, monoclonal antibodies and synthetic polypeptides that are analogues of HIV-1 and HIV-2 antigens. Experimental samples of the test kit are designed in the "sandwich" format of the solid-phase immunoassay analysis. According to the results of primary studies, experimental samples of test systems on diagnostic characteristics have a sensitivity and specificity of 100% in the study of human serum samples that have been characterized. Key words: immunoassay, monoclonal antibodies, recombinant proteins. Product Description popup.authors В.Д.Думанський В.О. Шевчук Л.М.Мойса Л.О.Ганова Н.О.Дмітрієва О.А.Петрик О.К.Кисельова Т.Ю.Трохимчук Ю.І.Горлов popup.nrat_date 2020-04-02 Close
R & D report
Head: Shevchuck Veronika Alexandrovna. Development of enzyme linked immunoassay of high sensitivity for p24 HIV1 and HIV2 specific antibodies detection. (popup.stage: ). Рrivate joint-stock company "Scientific production company "Diaproph-Med". № 0218U001105
1 documents found

Updated: 2026-03-26